Minimally invasive connective water vapor energy method for benign prostatic hyperplasia

Basit Öğe Kaydı
dc.contributor.authorÇakıroğlu, Basri
dc.date.accessioned2023-12-21T10:21:50Z
dc.date.available2023-12-21T10:21:50Z
dc.date.issued2023
dc.departmentMeslek Yüksekokulları, Meslek Yüksekokulu, Tıbbi Hizmetler ve Teknikler Bölümü
dc.description.abstractThe Rezum system has emerged as a promising treatment option for benign prostatic hyperplasia (BPH) by employing endoscopic removal of prostate tissue. This meta-analysis aimed to evaluate the benefits and drawbacks of Rezum therapy in recent studies. A systematic literature search was conducted in EMBASE, PubMed, and the Cochrane Library databases until December 2021, following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. The search utilized keywords such as water vapor thermal therapy, Rezum, convective water vapor thermal therapy, and convective radiofrequency water vapor thermal therapy. A total of 21 studies were included in the analysis, comprising 5 prospective randomized studies, 2 case series, 2 randomized controlled trials, 1 crossover study, and 11 retrospective studies. The collective sample involved 2090 patients with a mean follow-up period of 14.42 +/- 18.08 (1-72) months and a mean age of 68.12 +/- 4.79 years. Significant improvements were reported in the International Prostate Symptom Score (IPSS), quality of life (QoL), maximal flow rate (Qmax), postvoid residual urine volume (PVR), prostate volume (PV), and International Erectile Index Function (IIEF) values. Unlike other BPH treatments that often require general or regional anesthesia, the connective water vapor energy system can be administered with sedo-analgesia and local anesthesia, potentially leading to improved sexual function scores. Considering the relief of symptoms, Rezum therapy may serve as a viable alternative to transurethral surgery for patients with prostate volumes ranging from <30 to >80 cc.
dc.identifier.citationÇakıroğlu B. Minimally invasive connective water vapor energy method for benign prostatic hyperplasia. Urologia. 2023 Dec 9:3915603231216191. doi: 10.1177/03915603231216191. Epub ahead of print. PMID: 38069654.en_US
dc.identifier.doi10.1177/03915603231216191
dc.identifier.issn0391-5603
dc.identifier.issn1724-6075
dc.identifier.scopus2-s2.0-85179334432
dc.identifier.scopusqualityQ4
dc.identifier.urihttps://hdl.handle.net/20.500.12941/170
dc.identifier.wosWOS:001120674400001
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.institutionauthorÇakıroğlu, Basri
dc.language.isoen
dc.publisherSAGE Publications Ltd.
dc.relation.ispartofUrologia Journal
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectBenign prostatic hyperplasia
dc.subjectConnective water vapor energy
dc.subjectLower urinary tract symptoms
dc.titleMinimally invasive connective water vapor energy method for benign prostatic hyperplasia
dc.typeArticle

Dosyalar

Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama:
İndir

Koleksiyon

Meslek Yüksekokulu Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu